These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 18690954)

  • 1. Quality, safety and efficacy in the 'off-label' use of medicines.
    Kairuz TE; Gargiulo D; Bunt C; Garg S
    Curr Drug Saf; 2007 Jan; 2(1):89-95. PubMed ID: 18690954
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extemporaneous (magistral) preparation of oral medicines for children in European hospitals.
    Brion F; Nunn AJ; Rieutord A
    Acta Paediatr; 2003 Apr; 92(4):486-90. PubMed ID: 12801118
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pediatric Off-Label and Unlicensed Drug Use and Its Implications.
    Gore R; Chugh PK; Tripathi CD; Lhamo Y; Gautam S
    Curr Clin Pharmacol; 2017; 12(1):18-25. PubMed ID: 28322168
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Unlicensed and off-label drug use: issues and recommendations.
    Conroy S
    Paediatr Drugs; 2002; 4(6):353-9. PubMed ID: 12038871
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patient safety issues associated with the use of compounded medicines as alternatives to approved pharmaceutical products in Europe and how best practice can improve outcomes.
    Isles M
    Int J Risk Saf Med; 2020; 31(3):133-144. PubMed ID: 32538874
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unlicensed and off-label uses of medicines: definitions and clarification of terminology.
    Aronson JK; Ferner RE
    Br J Clin Pharmacol; 2017 Dec; 83(12):2615-2625. PubMed ID: 28779556
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Compounded medicines and 'off label' prescribing - a case for more guidance.
    Fois RA; Mewes BT; McLachlan AJ; Ramzan I
    Aust Fam Physician; 2009; 38(1-2):16-20. PubMed ID: 19283230
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Unlicensed pharmaceutical preparations for clinical patient care: Ensuring safety.
    de Wilde S; de Jong MGH; Le Brun PPH; Guchelaar HJ; Schimmel KJM
    Pharmacoepidemiol Drug Saf; 2018 Jan; 27(1):3-8. PubMed ID: 29047193
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unlicensed and off-label drug use in children: implications for safety.
    Choonara I; Conroy S
    Drug Saf; 2002; 25(1):1-5. PubMed ID: 11820908
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gamma sterilization of pharmaceuticals--a review of the irradiation of excipients, active pharmaceutical ingredients, and final drug product formulations.
    Hasanain F; Guenther K; Mullett WM; Craven E
    PDA J Pharm Sci Technol; 2014; 68(2):113-37. PubMed ID: 24668600
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacy compounding of high-risk level products and patient safety.
    Mullarkey T
    Am J Health Syst Pharm; 2009 Sep; 66(17 Suppl 5):S4-13. PubMed ID: 19710449
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Compounded medication for patients with rare diseases.
    Dooms M; Carvalho M
    Orphanet J Rare Dis; 2018 Jan; 13(1):1. PubMed ID: 29301541
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of Extemporaneous Prescriptions Prescribed by Dermatovenerologists in Latvia and Comparison with Standardized Compounded Preparation Monographs of Germany and USA.
    Kiseļova O; Mauriņa B; Šidlovska V
    Medicina (Kaunas); 2020 Jan; 56(1):. PubMed ID: 31936697
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Consensus SEO-SEFH of recommendations for use and compounding of ophthalmic preparations.
    Fuentes-Irigoyen R; Martín de Rosales Cabrera AM; Riestra AC; Vila MN; Dávila-Pousa C; Alonso Herreros JM; López-Cabezas C; Cañete C; Pernía-López MS; Garcia-Palomo M; Arriola Villalobos P; Ibares-Frías L; Urcelay Segura JL; Yañez Martínez JR
    Farm Hosp; 2018 Mar; 42(2):82-88. PubMed ID: 29501060
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extemporaneous compounding in veterinary practice: a New Zealand perspective.
    Gargiulo DA; Chemal C; Joda L; Lee YJ; Pilkington M; Haywood A; Garg S
    N Z Vet J; 2013 Nov; 61(6):311-5. PubMed ID: 23544952
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extemporaneous compounding in a sample of New Zealand hospitals: a retrospective survey.
    Kairuz T; Chhim S; Hasan F; Kumar K; Lal A; Patel R; Singh R; Dogra M; Garg S
    N Z Med J; 2007 Mar; 120(1251):U2466. PubMed ID: 17384694
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Off-Label Medication in Children: Responsibilities of Pediatrician and Neonatologist.
    Das JC; Hossain MA; Shahidullah M; Mannan MA
    Mymensingh Med J; 2018 Oct; 27(4):912-916. PubMed ID: 30487515
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Recommendations for the safety preparation of sterile medicines in medical wards].
    Martín de Rosales Cabrera AM; López Cabezas C; Pernía López MS; Dávila Pousa C; Vila Clérigues MN; Alonso Herreros JM; García Salom P; Lozano Blázquez A
    Farm Hosp; 2014 Jan; 38(1):57-64. PubMed ID: 24483861
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The use of unlicensed and off-label medicines in the neonate.
    Conroy S; McIntyre J
    Semin Fetal Neonatal Med; 2005 Apr; 10(2):115-22. PubMed ID: 15701577
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An Overview of Pharmaceutical Excipients: Safe or Not Safe?
    Abrantes CG; Duarte D; Reis CP
    J Pharm Sci; 2016 Jul; 105(7):2019-26. PubMed ID: 27262205
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.